# Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome

> **NCT01312402** · PHASE4 · COMPLETED · sponsor: **Akron Children's Hospital** · enrollment: 5 (actual)

## Conditions studied

- Infantile Nystagmus Syndrome

## Interventions

- **DRUG:** topical brinzolamide 1% in 5mL ophthalmic medication
- **DRUG:** Placebo in 5 mL dispenser

## Key facts

- **NCT ID:** NCT01312402
- **Lead sponsor:** Akron Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2014-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01312402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01312402, "Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01312402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*